Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
ArtivionAORT | Open-market sale10b5-1 plan | 06/11 | 06/15 | 44,001 sh2 trades | $20.70avg. | $910,660.71 | −42.2% | |
ArtivionAORT | Open-market sale | 03/03–03/04 | 03/04 | 12,805 sh2 trades | $37.93avg. | $485,744.54 | −6.5% | |
Amy HortonVP, Chief Accounting Officer | ArtivionAORT | Open-market sale | 03/03 | 03/04 | 901 sh | $37.78 | $34,039.78 | −0.6% |
James P. MackinPresident & CEO | ArtivionAORT | Open-market sale | 03/03 | 03/04 | 17,887 sh | $37.78 | $675,770.86 | −1.9% |
Lance A. BerryEVP, COO, CFO & Treasurer | ArtivionAORT | Open-market sale | 03/03 | 03/04 | 6,316 sh | $37.78 | $238,618.48 | −2.9% |
John E. DavisChief Commercial Officer | ArtivionAORT | Open-market sale | 03/03 | 03/04 | 4,573 sh | $37.78 | $172,767.94 | −1.9% |
Marshall S. StantonSVP, Clinical & MD Affair | ArtivionAORT | Open-market sale | 03/03 | 03/04 | 2,149 sh | $37.78 | $81,189.22 | −3.5% |
Amy HortonVP, Chief Accounting Officer | ArtivionAORT | Open-market sale | 03/02 | 03/03 | 641 sh | $38.02 | $24,370.82 | −0.5% |
James P. MackinPresident & CEO | ArtivionAORT | Open-market sale | 03/02 | 03/03 | 14,911 sh | $38.02 | $566,916.22 | −1.7% |
Lance A. BerryEVP, COO, CFO & Treasurer | ArtivionAORT | Open-market sale | 03/02 | 03/03 | 5,178 sh | $38.02 | $196,867.56 | −2.9% |
Holloway Jean F.SVP, General Counsel | ArtivionAORT | Open-market sale | 03/02 | 03/03 | 2,183 sh | $38.02 | $82,997.66 | −1.3% |
John E. DavisChief Commercial Officer | ArtivionAORT | Open-market sale | 03/02 | 03/03 | 2,784 sh | $38.02 | $105,847.68 | −1.3% |
Marshall S. StantonSVP, Clinical & MD Affair | ArtivionAORT | Open-market sale | 03/02 | 03/03 | 1,513 sh | $38.02 | $57,524.26 | −3.6% |
ArtivionAORT | Open-market sale | 02/23–02/24 | 02/25 | 2,561 sh2 trades | $36.97avg. | $94,690.99 | −2.0% | |
ArtivionAORT | Open-market sale | 02/23–02/24 | 02/25 | 34,898 sh2 trades | $36.83avg. | $1,285,337.42 | −4.4% | |
ArtivionAORT | Open-market sale | 02/23–02/24 | 02/25 | 9,466 sh2 trades | $36.69avg. | $347,305.44 | −6.2% | |
ArtivionAORT | Open-market sale | 02/23–02/24 | 02/25 | 4,747 sh2 trades | $36.92avg. | $175,270.53 | −3.0% | |
ArtivionAORT | Open-market sale | 02/23–02/24 | 02/25 | 5,848 sh2 trades | $36.92avg. | $215,883.82 | −3.0% | |
ArtivionAORT | Open-market sale | 02/23–02/24 | 02/25 | 3,682 sh2 trades | $36.94avg. | $136,014.28 | −8.1% | |
John E. DavisChief Commercial Officer | ArtivionAORT | Open-market sale | 25/12/15 | 25/12/17 | 5,000 sh | $45.11 | $225,550 | −2.5% |